James Aloysius Brady

Insider Reports History

Entity
Individual
Location
C/O Verona Pharma Plc, 3 More London Riverside, London, United Kingdom
Signature
/s/ Andrew Fisher, Attorney-in-fact for James Aloysius Brady
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Aloysius Brady:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xeris Biopharma Holdings, Inc. Director Common Stock 100K $543K $5.43 Mar 28, 2025 Direct
Verona Pharma plc Director Share Options (Right to Buy) 240K Apr 29, 2024 Direct
Verona Pharma plc Director Restricted Share Units 96K Apr 25, 2025 Direct

Insider Reports Filed by James Aloysius Brady

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRNA Verona Pharma plc Apr 25, 2025 1 $0 4 Apr 29, 2025 Director
XERS Xeris Biopharma Holdings, Inc. Mar 28, 2025 1 $0 4 Mar 28, 2025 Director
XERS Xeris Biopharma Holdings, Inc. Mar 28, 2025 0 $0 3 Mar 28, 2025 Director
VRNA Verona Pharma plc Apr 29, 2024 1 $0 4 Apr 30, 2024 Director
VRNA Verona Pharma plc Apr 28, 2023 1 $0 4 Apr 28, 2023 Director
VRNA Verona Pharma plc Mar 14, 2022 1 $0 4 Mar 16, 2022 Director
VRNA Verona Pharma plc Mar 14, 2022 0 $0 3 Mar 16, 2022 Director